메뉴 건너뛰기




Volumn 25, Issue 2, 2016, Pages 28-40

Overcoming Resistance to Endocrine Therapy in Breast Cancer: New Approaches to a Nagging Problem

Author keywords

Breast cancer; Endocrine resistance; Epithelial mesenchymal transition; Growth factor receptors; MicroRNA; Selective oestrogen receptor modulators; Tamoxifen

Indexed keywords

ANTAGOMIR; ANTIESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR BETA; GROWTH FACTOR; MICRORNA; TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; KERATINOCYTE GROWTH FACTOR; TUMOR MARKER;

EID: 84982843867     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000444451     Document Type: Conference Paper
Times cited : (28)

References (149)
  • 1
    • 34247508924 scopus 로고    scopus 로고
    • Unraveling the mechanisms of endocrine resistance in breast cancer: New therapeutic opportunities
    • Massarweh S, Schiff R: Unraveling the mechanisms of endocrine resistance in breast cancer: new therapeutic opportunities. Clin Cancer Res 2007;13:1950-1954.
    • (2007) Clin Cancer Res , vol.13 , pp. 1950-1954
    • Massarweh, S.1    Schiff, R.2
  • 2
    • 11244296162 scopus 로고    scopus 로고
    • Mechanisms of tamoxi-fen resistance
    • Ring A, Dowsett M: Mechanisms of tamoxi-fen resistance. Endocr Relat Cancer 2004; 11: 643-658.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 643-658
    • Ring, A.1    Dowsett, M.2
  • 3
    • 10644254128 scopus 로고    scopus 로고
    • Challenges in the endocrine management of breast cancer
    • Mouridsen HT, Rose C, Brodie AH, et al: Challenges in the endocrine management of breast cancer. Breast 2003;12:S2-S19.
    • (2003) Breast , vol.12 , pp. S2-S19
    • Mouridsen, H.T.1    Rose, C.2    Brodie, A.H.3
  • 4
    • 69249137029 scopus 로고    scopus 로고
    • Biological determinants of endocrine resistance in breast cancer
    • Musgrove EA, Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev 2009;9:631-643.
    • (2009) Nat Rev , vol.9 , pp. 631-643
    • Musgrove, E.A.1    Sutherland, R.L.2
  • 5
    • 0034466972 scopus 로고    scopus 로고
    • Estrogen receptor transcription and transacti-vation: Estrogen receptor alpha and estrogen receptor beta-regulation by selective estrogen receptor modulators and importance in breast cancer
    • Katzenellenbogen BS, Katzenellenbogen JA: Estrogen receptor transcription and transacti-vation: estrogen receptor alpha and estrogen receptor beta-regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Res 2000; 2:335-344.
    • (2000) Breast Cancer Res , vol.2 , pp. 335-344
    • Katzenellenbogen, B.S.1    Katzenellenbogen, J.A.2
  • 6
    • 84982791018 scopus 로고    scopus 로고
    • Endocrine resistance in breast cancer
    • Dixon MJ: Endocrine resistance in breast cancer. New J Sci 2014; 2014:1-27.
    • (2014) New J Sci , vol.2014 , pp. 1-27
    • Dixon, M.J.1
  • 7
    • 39149113165 scopus 로고    scopus 로고
    • Development of the 21-gene assay and its application in clinical practice and clinical trials
    • Sparano JA, Paik S: Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 2008; 26: 721-728.
    • (2008) J Clin Oncol , vol.26 , pp. 721-728
    • Sparano, J.A.1    Paik, S.2
  • 8
    • 33846869263 scopus 로고    scopus 로고
    • Resistance to endocrine therapy in breast cancer: Exploiting estrogen receptor/growth factor signaling crosstalk
    • Massarweh S, Schiff R: Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. Endocr Relat Cancer 2006; 13:S15-S24.
    • (2006) Endocr Relat Cancer , vol.13 , pp. S15-S24
    • Massarweh, S.1    Schiff, R.2
  • 9
    • 0032569831 scopus 로고    scopus 로고
    • Tamoxifen in the treatment of breast cancer
    • Osborne CK: Tamoxifen in the treatment of breast cancer. N Engl J Med 1998; 339:1609-1168.
    • (1998) N Engl J Med , vol.339 , pp. 1168-1609
    • Osborne, C.K.1
  • 10
    • 29144526402 scopus 로고    scopus 로고
    • Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
    • Normanno N, Maio MD, Maio ED, et al: Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. En-docr Relat Cancer 2005; 12:721-747.
    • (2005) En-docr Relat Cancer , vol.12 , pp. 721-747
    • Normanno, N.1    Maio, M.D.2    Maio, E.D.3
  • 11
    • 0028861586 scopus 로고
    • Use of tamoxifen for breast cancer: Twenty-eight years later
    • Jaiyesimi IA, Buzdar AU, Decker DA, et al: Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 1995; 13:513-529.
    • (1995) J Clin Oncol , vol.13 , pp. 513-529
    • Jaiyesimi, I.A.1    Buzdar, A.U.2    Decker, D.A.3
  • 12
    • 79959344615 scopus 로고    scopus 로고
    • Estrogen receptor silencing induces epithelial to mes-enchymal transition in human breast cancer cells
    • Al Saleh S, Al Mulla F, Luqmani YA: Estrogen receptor silencing induces epithelial to mes-enchymal transition in human breast cancer cells. PLoS One 2011;6:1-10.
    • (2011) PLoS One , vol.6 , pp. 1-10
    • Al Saleh, S.1    Al Mulla, F.2    Luqmani, Y.A.3
  • 13
    • 84896259336 scopus 로고    scopus 로고
    • The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy
    • Austreid E, Lonning PE, Eikesdal HP: The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy. Expert Opin Pharmaco-ther 2014; 15:681-700.
    • (2014) Expert Opin Pharmaco-ther , vol.15 , pp. 681-700
    • Austreid, E.1    Lonning, P.E.2    Eikesdal, H.P.3
  • 14
    • 84872188345 scopus 로고    scopus 로고
    • Mechanisms of resistance to endocrine therapy in breast cancer: Focus in signaling pathways, miRNAs and genetically based resistance
    • Gracía-Becerra R, Santos N, Díaz L, et al: Mechanisms of resistance to endocrine therapy in breast cancer: focus in signaling pathways, miRNAs and genetically based resistance. Int J Mol Sci 2013; 14:108-145.
    • (2013) Int J Mol Sci , vol.14 , pp. 108-145
    • Gracía-Becerra, R.1    Santos, N.2    Díaz, L.3
  • 15
    • 0034665358 scopus 로고    scopus 로고
    • Al-losteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351
    • MacGregor SJ, Liu H, Bentrem DJ, et al: Al-losteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351. Cancer Res 2000; 60:5097-5105.
    • (2000) Cancer Res , vol.60 , pp. 5097-5105
    • MacGregor, S.J.1    Liu, H.2    Bentrem, D.J.3
  • 16
    • 0033898141 scopus 로고    scopus 로고
    • A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
    • Fuqua SA, Wiltschke C, Zhang QX, et al: A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. Cancer Res 2000; 60:4026-4029.
    • (2000) Cancer Res , vol.60 , pp. 4026-4029
    • Fuqua, S.A.1    Wiltschke, C.2    Zhang, Q.X.3
  • 17
    • 84898756681 scopus 로고    scopus 로고
    • Estrogen receptor mutations in breast cancer-new focus on an old target
    • Segal CV, Dowsett M: Estrogen receptor mutations in breast cancer-new focus on an old target. Clin Cancer Res 2014; 20:1724-1726.
    • (2014) Clin Cancer Res , vol.20 , pp. 1724-1726
    • Segal, C.V.1    Dowsett, M.2
  • 18
    • 84884559238 scopus 로고    scopus 로고
    • Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xe-nografts
    • Li S, Shen D, Shao J, et al: Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xe-nografts. Cell Rep 2013; 4:1116-1130.
    • (2013) Cell Rep , vol.4 , pp. 1116-1130
    • Li, S.1    Shen, D.2    Shao, J.3
  • 19
    • 84942293346 scopus 로고    scopus 로고
    • ESR1 mutations: A mechanism for acquired endocrine resistance in breast cancer
    • Jeselsohn R, Buchwalter G, De Angelis C, et al: ESR1 mutations: a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol 2015; 12:573-583.
    • (2015) Nat Rev Clin Oncol , vol.12 , pp. 573-583
    • Jeselsohn, R.1    Buchwalter, G.2    De Angelis, C.3
  • 20
    • 0035477320 scopus 로고    scopus 로고
    • Syn-ergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells
    • Yang X, Phillips DL, Ferguson AT, et al: Syn-ergistic activation of functional estrogen receptor (ER)-α by DNA methyltransferase and histone deacetylase inhibition in human ER-α-negative breast cancer cells. Cancer Res 2001; 61:7025-7029.
    • (2001) Cancer Res , vol.61 , pp. 7025-7029
    • Yang, X.1    Phillips, D.L.2    Ferguson, A.T.3
  • 21
    • 0242659275 scopus 로고    scopus 로고
    • Multiple mechanisms of estrogen receptor gene repression contribute to ER-neg-ative breast cancer
    • Parl FF: Multiple mechanisms of estrogen receptor gene repression contribute to ER-neg-ative breast cancer. Pharmacogenomics J 2003; 3:251-253.
    • (2003) Pharmacogenomics J , vol.3 , pp. 251-253
    • Parl, F.F.1
  • 22
    • 85077951985 scopus 로고    scopus 로고
    • The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    • Marks PA: The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA). Cell Cycle 2004; 3:534-535.
    • (2004) Cell Cycle , vol.3 , pp. 534-535
    • Marks, P.A.1
  • 23
    • 44749085668 scopus 로고    scopus 로고
    • ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor
    • Fan J, Yin WJ, Lu JS, et al: ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor. J Cancer Res Clin Oncol 2008; 134:883-890.
    • (2008) J Cancer Res Clin Oncol , vol.134 , pp. 883-890
    • Fan, J.1    Yin, W.J.2    Lu, J.S.3
  • 24
    • 68949105725 scopus 로고    scopus 로고
    • Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells
    • Zhou Q, Shaw PG, Davidson NE: Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells. Breast Cancer Res Treat 2009; 117:443-451.
    • (2009) Breast Cancer Res Treat , vol.117 , pp. 443-451
    • Zhou, Q.1    Shaw, P.G.2    Davidson, N.E.3
  • 25
    • 79952237710 scopus 로고    scopus 로고
    • Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole
    • Sabnis GJ, Goloubeva O, Chumsri S, et al: Functional activation of the estrogen recep-tor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole. Cancer Res 2011; 71:1893-1903.
    • (2011) Cancer Res , vol.71 , pp. 1893-1903
    • Sabnis, G.J.1    Goloubeva, O.2    Chumsri, S.3
  • 26
    • 84862656616 scopus 로고    scopus 로고
    • Scrip-taid effects on breast cancer cell lines
    • Giacinti L, Giacinti C, Gabellini C, et al: Scrip-taid effects on breast cancer cell lines. J Cell Physiol 2012; 227:3426-3433.
    • (2012) J Cell Physiol , vol.227 , pp. 3426-3433
    • Giacinti, L.1    Giacinti, C.2    Gabellini, C.3
  • 27
    • 0036488531 scopus 로고    scopus 로고
    • Endocrine-responsive breast cancer and strategies for combating resistance
    • Ali S, Coombes RC: Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2002;2:101-112.
    • (2002) Nat Rev Cancer , vol.2 , pp. 101-112
    • Ali, S.1    Coombes, R.C.2
  • 28
    • 69249137029 scopus 로고    scopus 로고
    • Biological determinants of endocrine resistance in breast cancer
    • Musgrove EA, Sutherland RL: Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 2009; 9:631-643.
    • (2009) Nat Rev Cancer , vol.9 , pp. 631-643
    • Musgrove, E.A.1    Sutherland, R.L.2
  • 29
    • 63749086305 scopus 로고    scopus 로고
    • ErbB receptors and signaling pathways in cancer
    • Hynes NE, MacDonald G: ErbB receptors and signaling pathways in cancer. Curr Opin Cell Biol 2009; 21:1777-1784.
    • (2009) Curr Opin Cell Biol , vol.21 , pp. 1777-1784
    • Hynes, N.E.1    MacDonald, G.2
  • 30
    • 2942652871 scopus 로고    scopus 로고
    • Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu crosstalk in ER/HER2-positive breast cancer
    • Shou J, Massarweh S, Osborne CK, et al: Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu crosstalk in ER/HER2-positive breast cancer. J Natl Cancer Inst 2004; 96:926-935.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 926-935
    • Shou, J.1    Massarweh, S.2    Osborne, C.K.3
  • 31
    • 77956251261 scopus 로고    scopus 로고
    • Simultaneous targeting of estrogen receptor and HER2 in breast cancer
    • Azim HA Jr, Piccart MJ: Simultaneous targeting of estrogen receptor and HER2 in breast cancer. Expert Rev Anticancer Ther 2010; 10: 1255-1263.
    • (2010) Expert Rev Anticancer Ther , vol.10 , pp. 1255-1263
    • Azim, H.A.1    Piccart, M.J.2
  • 32
    • 51049118140 scopus 로고    scopus 로고
    • An integrative genomic and pro-teomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer
    • Stemke-Hale K, Gonzalez-Angulo AM, Lluch A, et al: An integrative genomic and pro-teomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. Cancer Res 2008; 68:6084-6091.
    • (2008) Cancer Res , vol.68 , pp. 6084-6091
    • Stemke-Hale, K.1    Gonzalez-Angulo, A.M.2    Lluch, A.3
  • 33
    • 0035971181 scopus 로고    scopus 로고
    • Phosphatidylinositol 3-kinase/AKT-medi-ated activation of estrogen receptor alpha: A new model for anti-estrogen resistance
    • Campbell RA, Bhat-Nakshatri P, Patel NM, et al: Phosphatidylinositol 3-kinase/AKT-medi-ated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem 2001; 276:9817-9824.
    • (2001) J Biol Chem , vol.276 , pp. 9817-9824
    • Campbell, R.A.1    Bhat-Nakshatri, P.2    Patel, N.M.3
  • 34
    • 0034794636 scopus 로고    scopus 로고
    • Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer
    • Dowsett M: Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer. Endocr Relat Cancer 2001; 8: 191-195.
    • (2001) Endocr Relat Cancer , vol.8 , pp. 191-195
    • Dowsett, M.1
  • 35
    • 79952135852 scopus 로고    scopus 로고
    • The IGF pathway regulates ERalpha through a S6K1-dependent mechanism in breast cancer cells
    • Becker MA, Ibrahim YH, Cui X, et al: The IGF pathway regulates ERalpha through a S6K1-dependent mechanism in breast cancer cells. Mol Endocrinol 2011; 25:516-528.
    • (2011) Mol Endocrinol , vol.25 , pp. 516-528
    • Bonelli, M.A.1    Ibrahim, Y.H.2    Cui, X.3
  • 36
    • 77950793617 scopus 로고    scopus 로고
    • EGFR/HER2 inhibitor AEE788 increases ER-me-diated transcription in HER2/ER-positive breast cancer cells but functions synergisti-cally with endocrine therapy
    • Evans AH, Pancholi S, Farmer I, et al: EGFR/HER2 inhibitor AEE788 increases ER-me-diated transcription in HER2/ER-positive breast cancer cells but functions synergisti-cally with endocrine therapy. Br J Cancer 2010; 102:1235-1243.
    • (2010) Br J Cancer , vol.102 , pp. 1235-1243
    • Evans, A.H.1    Pancholi, S.2    Farmer, I.3
  • 37
    • 84861823850 scopus 로고    scopus 로고
    • Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
    • Cavazzoni A, Bonelli MA, Fumarola C, et al: Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. Cancer Lett 2012; 323:77-87.
    • (2012) Cancer Lett , vol.323 , pp. 77-87
    • Cavazzoni, A.1    Bonelli, M.A.2    Fumarola, C.3
  • 38
    • 84880264411 scopus 로고    scopus 로고
    • Molecular characterization of anastrozole resistance in breast cancer: Pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor
    • Vilquin P, Villedieu M, Grisard E, et al: Molecular characterization of anastrozole resistance in breast cancer: pivotal role of the Akt/mTOR pathway in the emergence of de novo or acquired resistance and importance of combining the allosteric Akt inhibitor MK-2206 with an aromatase inhibitor. Int J Cancer 2013; 133:1589-1602.
    • (2013) Int J Cancer , vol.133 , pp. 1589-1602
    • Vilquin, P.1    Villedieu, M.2    Grisard, E.3
  • 39
    • 84876204394 scopus 로고    scopus 로고
    • Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer
    • Magnani L, Stoeck A, Zhang X, et al: Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci USA 2013; 110:E1490-E1499.
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. E1490-E1499
    • Magnani, L.1    Stoeck, A.2    Zhang, X.3
  • 40
    • 84866145981 scopus 로고    scopus 로고
    • The interaction between ER and NFκB in resistance to endocrine therapy
    • Sas L, Lardon F, Vermeulen PB, et al: The interaction between ER and NFκB in resistance to endocrine therapy. Breast Cancer Res 2012; 14:212-216.
    • (2012) Breast Cancer Res , vol.14 , pp. 212-216
    • Sas, L.1    Lardon, F.2    Vermeulen, P.B.3
  • 41
    • 84907873145 scopus 로고    scopus 로고
    • Endocrine resistance in breast cancer
    • Zheng LH, Zhao YH, Feng HL, et al: Endocrine resistance in breast cancer. Climacteric 2014; 17:522-528.
    • (2014) Climacteric , vol.17 , pp. 522-528
    • Zheng, L.H.1    Zhao, Y.H.2    Feng, H.L.3
  • 42
    • 34247242607 scopus 로고    scopus 로고
    • Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer
    • Zhou Y, Yau C, Gray JW, et al: Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer. BMC Cancer 2007; 7:59.
    • (2007) BMC Cancer , vol.7 , pp. 59
    • Zhou, Y.1    Yau, C.2    Gray, J.W.3
  • 43
    • 3442901974 scopus 로고    scopus 로고
    • NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen
    • deGraffenried LA, Chandrasekar B, Fried-richs WE, et al: NF-κB inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol 2006; 15: 885-890.
    • (2006) Ann Oncol , vol.15 , pp. 885-890
    • DeGraffenried, L.A.1    Chandrasekar, B.2    Fried-Richs, W.E.3
  • 45
    • 23244451640 scopus 로고    scopus 로고
    • Mac-rophages induce invasiveness of epithelial cancer cells via NF-κB and JNK
    • Hagemann T, Wilson J, Kulbe H, et al: Mac-rophages induce invasiveness of epithelial cancer cells via NF-κB and JNK. J Immunol 2005; 175:1197-1205.
    • (2005) J Immunol , vol.175 , pp. 1197-1205
    • Hagemann, T.1    Wilson, J.2    Kulbe, H.3
  • 46
    • 66349123393 scopus 로고    scopus 로고
    • Tamoxifen metabolism and its effect on endocrine treatment of breast cancer
    • Briest S, Stearns V: Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. Clin Adv Hematol Oncol 2009; 7:185-192.
    • (2009) Clin Adv Hematol Oncol , vol.7 , pp. 185-192
    • Briest, S.1    Stearns, V.2
  • 47
    • 79951891762 scopus 로고    scopus 로고
    • Endoxifen, the active metabolite to tamoxifen, is a substrate of efflux transporter P-glycoprotein (multi-drug resistance 1)
    • Teft WA, Mansell SE, Kim RB: Endoxifen, the active metabolite to tamoxifen, is a substrate of efflux transporter P-glycoprotein (multi-drug resistance 1). Drug Metab Dispos 2011; 39:558-562.
    • (2011) Drug Metab Dispos , vol.39 , pp. 558-562
    • Teft, W.A.1    Mansell, S.E.2    Kim, R.B.3
  • 48
    • 11244296162 scopus 로고    scopus 로고
    • Mechanisms of tamoxi-fen resistance
    • Ring A, Dowsett M: Mechanisms of tamoxi-fen resistance. Endocr Relat Cancer 2004; 11: 643-658.
    • (2004) Endocr Relat Cancer , vol.11 , pp. 643-658
    • Ring, A.1    Dowsett, M.2
  • 49
    • 77955661193 scopus 로고    scopus 로고
    • Orally administered endoxifen is a new therapeutic agent for breast cancer
    • Ahmad A, Ali SM, Ahmad MU, et al: Orally administered endoxifen is a new therapeutic agent for breast cancer. Breast Cancer Res Treat 2010; 122:579-584.
    • (2010) Breast Cancer Res Treat , vol.122 , pp. 579-584
    • Ahmad, A.1    Ali, S.M.2    Ahmad, M.U.3
  • 50
    • 0034466973 scopus 로고    scopus 로고
    • Estrogen receptor transcription and transactivation: Basic aspects of estrogen action
    • Nilsson S, Gustafsson J-A: Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res 2000; 2:360-366.
    • (2000) Breast Cancer Res , vol.2 , pp. 360-366
    • Nilsson, S.1    Gustafsson, J.-A.2
  • 51
    • 0034868904 scopus 로고    scopus 로고
    • ERβ inhibits proliferation and invasion of breast cancer cells
    • Lazennec G, Bresson D, Lucas A, et al: ERβ inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001; 142:4120-4130.
    • (2001) Endocrinology , vol.142 , pp. 4120-4130
    • Lazennec, G.1    Bresson, D.2    Lucas, A.3
  • 52
    • 9344264630 scopus 로고    scopus 로고
    • Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer
    • Hopp TA, Weiss HL, Parra IS, et al: Low levels of estrogen receptor β protein predict resistance to tamoxifen therapy in breast cancer. Clin Cancer Res 2004; 10:7490-7499.
    • (2004) Clin Cancer Res , vol.10 , pp. 7490-7499
    • Hopp, T.A.1    Weiss, H.L.2    Parra, I.S.3
  • 53
    • 0037025323 scopus 로고    scopus 로고
    • Opposing action of estrogen receptor α and β on cyclin D1 gene expression
    • Liu M-M, Albanese C, Anderson CM, et al: Opposing action of estrogen receptor α and β on cyclin D1 gene expression. J Biol Chem 2002; 277:24353-24360.
    • (2002) J Biol Chem , vol.277 , pp. 24353-24360
    • Liu, M.-M.1    Albanese, C.2    Anderson, C.M.3
  • 54
    • 0030801841 scopus 로고    scopus 로고
    • Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP-1 sites
    • Paech KM, Webb P, Kuiper GG, et al: Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP-1 sites. Science 1997; 277:1508-1510.
    • (1997) Science , vol.277 , pp. 1508-1510
    • Paech, K.M.1    Webb, P.2    Kuiper, G.G.3
  • 55
    • 0033524443 scopus 로고    scopus 로고
    • Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium
    • Shim W-S, DiRenzo J, DeCaprio JA, et al: Segregation of steroid receptor coactivator-1 from steroid receptors in mammary epithelium. Proc Natl Acad Sci USA 1999;96:208-213.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 208-213
    • Shim, W.-S.1    DiRenzo, J.2    DeCaprio, J.A.3
  • 56
    • 0032230350 scopus 로고    scopus 로고
    • Estrogen receptor activation function 1 works by binding p160 co-activator proteins
    • Webb P, Nguyen P, Shinsako J, et al: Estrogen receptor activation function 1 works by binding p160 co-activator proteins. Mol Endocri-nol 1998; 12:1605-1618.
    • (1998) Mol Endocri-nol , vol.12 , pp. 1605-1618
    • Webb, P.1    Nguyen, P.2    Shinsako, J.3
  • 57
    • 11744282298 scopus 로고    scopus 로고
    • Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes
    • Lavinsky RM, Jepsen K, Heinzel T, et al: Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci USA 1998;95: 2920-2925.
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 2920-2925
    • Lavinsky, R.M.1    Jepsen, K.2    Heinzel, T.3
  • 58
    • 84887613510 scopus 로고    scopus 로고
    • Tumor and its microenvironment: A synergistic interplay
    • Catalano V, Turdo A, Franco SD, et al: Tumor and its microenvironment: a synergistic interplay. Semin Cancer Biol 2013; 23:522-532.
    • (2013) Semin Cancer Biol , vol.23 , pp. 522-532
    • Catalano, V.1    Turdo, A.2    Franco, S.D.3
  • 59
    • 5044238876 scopus 로고    scopus 로고
    • Integrin signaling during tumor progression
    • Guo W, Giancotti FG: Integrin signaling during tumor progression. Nat Rev 2004;5:816-826.
    • (2004) Nat Rev , vol.5 , pp. 816-826
    • Guo, W.1    Giancotti, F.G.2
  • 61
    • 33746764457 scopus 로고    scopus 로고
    • 4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis
    • 4 Integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006; 126:489-502.
    • (2006) Cell , vol.126 , pp. 489-502
    • Guo, W.1    Pylayeva, Y.2    Pepe, A.3
  • 62
    • 0029564954 scopus 로고
    • Heat shock transcription factors: Structure and regulation
    • Wu C: Heat shock transcription factors: structure and regulation. Ann Rev Cell Dev Biol 1995;11:441-469.
    • (1995) Ann Rev Cell Dev Biol , vol.11 , pp. 441-469
    • Wu, C.1
  • 63
    • 17844394391 scopus 로고    scopus 로고
    • Mitogen-activated protein kinase activation in UV-induced signal trans-duction
    • Bode AM, Dong Z: Mitogen-activated protein kinase activation in UV-induced signal trans-duction. Sci STKE 2003;167:RE2.
    • (2003) Sci STKE , vol.167 , pp. RE2
    • Bode, A.M.1    Dong, Z.2
  • 64
    • 0141509074 scopus 로고    scopus 로고
    • Cancer: The rules of attraction
    • Neckers L, Lee YS: Cancer: the rules of attraction. Nature 2003;425:357-359.
    • (2003) Nature , vol.425 , pp. 357-359
    • Neckers, L.1    Lee, Y.S.2
  • 65
    • 17844398046 scopus 로고    scopus 로고
    • Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
    • Gutierrez MC, Detre S, Johnston S, et al: Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. J Clin Oncol 2005; 23:2469-2476.
    • (2005) J Clin Oncol , vol.23 , pp. 2469-2476
    • Gutierrez, M.C.1    Detre, S.2    Johnston, S.3
  • 66
    • 74949101730 scopus 로고    scopus 로고
    • Challenges in defining predictive markers for response to endocrine therapy in breast cancer
    • Larionov AA, Miller WR: Challenges in defining predictive markers for response to endocrine therapy in breast cancer. Future Oncol 2009; 5:1415-1428.
    • (2009) Future Oncol , vol.5 , pp. 1415-1428
    • Larionov, A.A.1    Miller, W.R.2
  • 67
    • 77950362569 scopus 로고    scopus 로고
    • Aromatase resistance mechanisms in model systems in vivo
    • Brodie A, Macedo L, Sabnis G: Aromatase resistance mechanisms in model systems in vivo. J Steroid Biochem Molec Biol 2010; 118: 283-287.
    • (2010) J Steroid Biochem Molec Biol , vol.118 , pp. 283-287
    • Brodie, A.1    MacEdo, L.2    Sabnis, G.3
  • 68
    • 63049137792 scopus 로고    scopus 로고
    • Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole
    • Miller WR, Larionov A, Renshaw L, et al: Gene expression profiles differentiating between breast cancers clinically responsive or resistant to letrozole. J Clin Oncol 2009; 27: 1382-1387.
    • (2009) J Clin Oncol , vol.27 , pp. 1382-1387
    • Miller, W.R.1    Larionov, A.2    Renshaw, L.3
  • 69
    • 1642386264 scopus 로고    scopus 로고
    • Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model
    • Long BJ, Jelovac D, Handratta V, et al: Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model. J Natl Cancer Inst 2004; 96:456-465.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 456-465
    • Long, B.J.1    Jelovac, D.2    Handratta, V.3
  • 70
    • 20444448539 scopus 로고    scopus 로고
    • Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model
    • Jelovac D, Macedo L, Goloubeva OG, et al: Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model. Cancer Res 2005; 65:5439-5444.
    • (2005) Cancer Res , vol.65 , pp. 5439-5444
    • Jelovac, D.1    MacEdo, L.2    Goloubeva, O.G.3
  • 71
    • 84867891436 scopus 로고    scopus 로고
    • Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: Where are we now and where are we going?
    • Fedele P, Calvani N, Marino A, et al: Targeted agents to reverse resistance to endocrine therapy in metastatic breast cancer: where are we now and where are we going? Crit Rev Oncol Hematol 2012; 84:243-251.
    • (2012) Crit Rev Oncol Hematol , vol.84 , pp. 243-251
    • Fedele, P.1    Calvani, N.2    Marino, A.3
  • 72
    • 84861823850 scopus 로고    scopus 로고
    • Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
    • Cavazzoni A, Bonelli MA, Fumarola C, et al: Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones. Cancer Lett 2012; 323:77-87.
    • (2012) Cancer Lett , vol.323 , pp. 77-87
    • Cavazzoni, A.1    Bonelli, M.A.2    Fumarola, C.3
  • 73
    • 84864107018 scopus 로고    scopus 로고
    • Everolimus: Targeted therapy on the horizon for the treatment of breast cancer
    • Barnett CM: Everolimus: targeted therapy on the horizon for the treatment of breast cancer. Pharmacotherapy 2012; 32:383-396.
    • (2012) Pharmacotherapy , vol.32 , pp. 383-396
    • Barnett, C.M.1
  • 74
    • 84893646332 scopus 로고    scopus 로고
    • A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure
    • Massarweh S, Romond E, Black EP, et al: A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure. Breast Cancer Res Treat 2014; 143:325-332.
    • (2014) Breast Cancer Res Treat , vol.143 , pp. 325-332
    • Massarweh, S.1    Romond, E.2    Black, E.P.3
  • 75
    • 0020358296 scopus 로고
    • Epithelial suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells
    • Greenburg G, Hay ED: Epithelial suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 1982; 95:335-339.
    • (1982) J Cell Biol , vol.95 , pp. 335-339
    • Greenburg, G.1    Hay, E.D.2
  • 76
    • 34447272058 scopus 로고    scopus 로고
    • Mechanisms of metastasis: Epithelial-mesenchymal transition and contribution of tumor microenvironment
    • Tse JC, Kalluri R: Mechanisms of metastasis: epithelial-mesenchymal transition and contribution of tumor microenvironment. J Cell Biol 2007; 101:816-829.
    • (2007) J Cell Biol , vol.101 , pp. 816-829
    • Tse, J.C.1    Kalluri, R.2
  • 77
    • 84873050284 scopus 로고    scopus 로고
    • Regulatory network defining EMT during cancer initiation and progression
    • De Craene B, Berx G: Regulatory network defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13:97-110.
    • (2013) Nat Rev Cancer , vol.13 , pp. 97-110
    • De Craene, B.1    Berx, G.2
  • 78
    • 0033784843 scopus 로고    scopus 로고
    • The transcription factor Snail controls epithe-lial-mesenchymal transitions by repressing E-cadherin expression
    • Cano A, Perez-Moreno MA, Rodrigo I, et al: The transcription factor Snail controls epithe-lial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000; 2:76-83.
    • (2000) Nat Cell Biol , vol.2 , pp. 76-83
    • Cano, A.1    Perez-Moreno, M.A.2    Rodrigo, I.3
  • 79
    • 33750358078 scopus 로고    scopus 로고
    • Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition
    • Moreno-Bueno G, Cubillo E, Sarrio D, et al: Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 2006; 66: 9543-9556.
    • (2006) Cancer Res , vol.66 , pp. 9543-9556
    • Moreno-Bueno, G.1    Cubillo, E.2    Sarrio, D.3
  • 80
    • 33244463813 scopus 로고    scopus 로고
    • Complex networks orchestrate epithelial-mesenchymal transition
    • Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transition. Mol Cell Biol 2006; 7:131-142.
    • (2006) Mol Cell Biol , vol.7 , pp. 131-142
    • Thiery, J.P.1    Sleeman, J.P.2
  • 81
    • 64549090709 scopus 로고    scopus 로고
    • Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition
    • Sivakumar R, Koga H, Selvendiran K, et al: Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition. Intl J Oncol 2009; 34:392-338.
    • (2009) Intl J Oncol , vol.34 , pp. 338-392
    • Sivakumar, R.1    Koga, H.2    Selvendiran, K.3
  • 82
    • 65349116534 scopus 로고    scopus 로고
    • Trans-lational activation of snail1 and other devel-opmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition
    • Evdokimova V, Tognon C, Ng T, et al: Trans-lational activation of snail1 and other devel-opmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009; 15:402-415.
    • (2009) Cancer Cell , vol.15 , pp. 402-415
    • Evdokimova, V.1    Tognon, C.2    Ng, T.3
  • 83
    • 12144266241 scopus 로고    scopus 로고
    • Gly-cogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: Implications for the epithelial-mesenchymal transition
    • Bachelder RE, Yoon SO, Franci C, et al: Gly-cogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005; 168:29-33.
    • (2005) J Cell Biol , vol.168 , pp. 29-33
    • Bachelder, R.E.1    Yoon, S.O.2    Franci, C.3
  • 84
    • 77952952860 scopus 로고    scopus 로고
    • Role of CK1 in GSK3β-mediated phosphorylation and degradation of snail
    • Xu Y, Lee SH, Kim HS, et al: Role of CK1 in GSK3β-mediated phosphorylation and degradation of snail. Oncogene 2010; 29:3124-3133.
    • (2010) Oncogene , vol.29 , pp. 3124-3133
    • Xu, Y.1    Lee, S.H.2    Kim, H.S.3
  • 85
    • 77950346282 scopus 로고    scopus 로고
    • Immunity, inflammation, and cancer
    • Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer. Cell 2010; 140:883-899.
    • (2010) Cell , vol.140 , pp. 883-899
    • Grivennikov, S.I.1    Greten, F.R.2    Karin, M.3
  • 86
    • 0033578314 scopus 로고    scopus 로고
    • Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma
    • Ge K, DuHadaway J, Du W, et al: Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 1999; 96:9689-9694.
    • (1999) Proc Natl Acad Sci USA , vol.96 , pp. 9689-9694
    • Ge, K.1    DuHadaway, J.2    Du, W.3
  • 87
    • 84941243013 scopus 로고    scopus 로고
    • Distinct EMT programs control normal mammary stem cells and tumour-initiating cells
    • Ye X, Tam WL, Shibue T, et al: Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. Nature 2015; 525:256-260.
    • (2015) Nature , vol.525 , pp. 256-260
    • Ye, X.1    Tam, W.L.2    Shibue, T.3
  • 88
    • 77949423072 scopus 로고    scopus 로고
    • ERα signaling through slug regulates E-cadherin and EMT
    • Ye Y, Xiao Y, Wang W, et al: ERα signaling through slug regulates E-cadherin and EMT. Oncogene 2010; 29:1451-1462.
    • (2010) Oncogene , vol.29 , pp. 1451-1462
    • Ye, Y.1    Xiao, Y.2    Wang, W.3
  • 89
    • 79951681780 scopus 로고    scopus 로고
    • Drug resistant MCF-7 cells exhibit epithelial-mes-enchymal transition gene expression pattern
    • Iseri OD, Kars MD, Arpaci F, et al: Drug resistant MCF-7 cells exhibit epithelial-mes-enchymal transition gene expression pattern. Biomed Pharmacother 2011; 65:40-45.
    • (2011) Biomed Pharmacother , vol.65 , pp. 40-45
    • Iseri, O.D.1    Kars, M.D.2    Arpaci, F.3
  • 90
    • 0035496541 scopus 로고    scopus 로고
    • The role of c-ErbB-2/HER2/neu in breast cancer progression and metastasis
    • Eccles SA: The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neoplasia 2001; 6: 393-406.
    • (2001) J Mammary Gland Biol Neoplasia , vol.6 , pp. 393-406
    • Eccles, S.A.1
  • 91
    • 0026443229 scopus 로고
    • Mechanisms of c-erbB2-2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products
    • Yu D, Hamada J, Zhand H, et al: Mechanisms of c-erbB2-2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. Oncogene 1992; 7:2263-2270.
    • (1992) Oncogene , vol.7 , pp. 2263-2270
    • Yu, D.1    Hamada, J.2    Zhand, H.3
  • 92
    • 84862820130 scopus 로고    scopus 로고
    • Epithelial-mes-enchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype
    • Jeong H, Ryu Y-J, An J, et al: Epithelial-mes-enchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. Histopathol 2012; 60: E87-E95.
    • (2012) Histopathol , vol.60 , pp. E87-E95
    • Jeong, H.1    Ryu, Y.-J.2    An, J.3
  • 93
    • 60749137227 scopus 로고    scopus 로고
    • Modification of gene expression induced by siRNA targeting of estrogen receptor in MCF-7 human breast cancer cells
    • Luqmani YA, Al Azmi A, Al Bader M, et al: Modification of gene expression induced by siRNA targeting of estrogen receptor in MCF-7 human breast cancer cells. Int J Oncol 2009; 34:231-242.
    • (2009) Int J Oncol , vol.34 , pp. 231-242
    • Luqmani, Y.A.1    Al Azmi, A.2    Al Bader, M.3
  • 94
    • 36849002930 scopus 로고    scopus 로고
    • The transcription factor snail mediates epithelial to mesenchymal transition by repression of estrogen receptor-α
    • Dhasarathy A, Kajita M, Wade PA: The transcription factor snail mediates epithelial to mesenchymal transition by repression of estrogen receptor-α. Mol Endocrinol 2007; 21: 2907-2918.
    • (2007) Mol Endocrinol , vol.21 , pp. 2907-2918
    • Dhasarathy, A.1    Kajita, M.2    Wade, P.A.3
  • 95
    • 80052403945 scopus 로고    scopus 로고
    • The EMT regulator slug and lung carcinogenesis
    • Shih J-Y, Yang P-C: The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011; 32:1299-1304.
    • (2011) Carcinogenesis , vol.32 , pp. 1299-1304
    • Shih, J.-Y.1    Yang, P.-C.2
  • 96
    • 84982791018 scopus 로고    scopus 로고
    • Endocrine resistance in breast cancer
    • Dixon MJ: Endocrine resistance in breast cancer. New J Sci 2014; 2014:1-27.
    • (2014) New J Sci , vol.2014 , pp. 1-27
    • Dixon, M.J.1
  • 97
    • 79954999152 scopus 로고    scopus 로고
    • Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition
    • Al Saleh S, Sharaf LH, Luqmani YA: Signalling pathways involved in endocrine resistance in breast cancer and associations with epithelial to mesenchymal transition. Int J Oncol 2011a;38: 1197-1217.
    • (2011) Int J Oncol , vol.38 , pp. 1197-1217
    • Al Saleh, S.1    Sharaf, L.H.2    Luqmani, Y.A.3
  • 98
    • 84875505291 scopus 로고    scopus 로고
    • The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer
    • Loh YN, Hedditch EL, Baker LA, et al: The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer. BMC Cancer 2013; 13: 174-181.
    • (2013) BMC Cancer , vol.13 , pp. 174-181
    • Loh, Y.N.1    Hedditch, E.L.2    Baker, L.A.3
  • 99
    • 84896489562 scopus 로고    scopus 로고
    • Eribu-lin mesilate suppresses experimental metastasis of breast cancer cells by reversing phe-notype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states
    • Yoshida T, Ozawa Y, Kimura T, et al: Eribu-lin mesilate suppresses experimental metastasis of breast cancer cells by reversing phe-notype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer 2014; 110:1497-1505.
    • (2014) Br J Cancer , vol.110 , pp. 1497-1505
    • Yoshida, T.1    Ozawa, Y.2    Kimura, T.3
  • 100
    • 84910639102 scopus 로고    scopus 로고
    • Centchro-man suppresses breast cancer metastasis by reversing epithelialmesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling
    • Khan S, Shukla S, Sinha S, et al: Centchro-man suppresses breast cancer metastasis by reversing epithelialmesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling. Intl J Biochem Cell Biol 2014; 58:1-16.
    • (2014) Intl J Biochem Cell Biol , vol.58 , pp. 1-16
    • Khan, S.1    Shukla, S.2    Sinha, S.3
  • 101
    • 77953765387 scopus 로고    scopus 로고
    • Doxorubicin in combination with a small TGFβ inhibitor: A potential novel therapy for metastatic breast cancer in mouse models
    • Bandyopadhyay A, Wang L, Agyin J, et al: Doxorubicin in combination with a small TGFβ inhibitor: a potential novel therapy for metastatic breast cancer in mouse models. PLoS One 2010; 5:1-13.
    • (2010) PLoS One , vol.5 , pp. 1-13
    • Bandyopadhyay, A.1    Wang, L.2    Agyin, J.3
  • 102
    • 84860386584 scopus 로고    scopus 로고
    • MiRNAs and estrogen action
    • Klinge CM: miRNAs and estrogen action. Trends Endocrinol Metab 2012; 23:223-233.
    • (2012) Trends Endocrinol Metab , vol.23 , pp. 223-233
    • Klinge, C.M.1
  • 103
    • 72949098057 scopus 로고    scopus 로고
    • Therapeutic microRNA strategies in human cancer
    • Li C, Feng Y, Coukos G, et al: Therapeutic microRNA strategies in human cancer. AAPS J 2009; 11:747-757.
    • (2009) AAPS J , vol.11 , pp. 747-757
    • Li, C.1    Feng, Y.2    Coukos, G.3
  • 104
    • 80054090363 scopus 로고    scopus 로고
    • Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells
    • Manavalan TT, Teng Y, Appana SN, et al: Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett 2011; 313:26-43.
    • (2011) Cancer Lett , vol.313 , pp. 26-43
    • Manavalan, T.T.1    Teng, Y.2    Appana, S.N.3
  • 105
    • 38549120730 scopus 로고    scopus 로고
    • Profiling microRNA expression with microarrays
    • Yin JQ, Zhao RC, Morris KV: Profiling microRNA expression with microarrays. Trends Biotechnol 2008; 26:70-76.
    • (2008) Trends Biotechnol , vol.26 , pp. 70-76
    • Yin, J.Q.1    Zhao, R.C.2    Morris, K.V.3
  • 106
    • 77956501846 scopus 로고    scopus 로고
    • Modulation of K-Ras-dependent lung tu-morigenesis by microRNA-21
    • Hatley ME, Patrick DM, Garcia MR, et al: Modulation of K-Ras-dependent lung tu-morigenesis by microRNA-21. Cancer Cell 2010; 18:282-293.
    • (2010) Cancer Cell , vol.18 , pp. 282-293
    • Hatley, M.E.1    Patrick, D.M.2    Garcia, M.R.3
  • 107
    • 77954030587 scopus 로고    scopus 로고
    • Genetic variation in microRNA networks: The implications for cancer research
    • Ryan BM, Robles AI, Harris CC: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10:389-402.
    • (2010) Nat Rev Cancer , vol.10 , pp. 389-402
    • Ryan, B.M.1    Robles, A.I.2    Harris, C.C.3
  • 108
    • 77957091969 scopus 로고    scopus 로고
    • Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis
    • Kosaka N, Iguchi H, Ochiya T: Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. J Cancer Sci 2010; 101:2087-2092.
    • (2010) J Cancer Sci , vol.101 , pp. 2087-2092
    • Kosaka, N.1    Iguchi, H.2    Ochiya, T.3
  • 110
    • 84863906869 scopus 로고    scopus 로고
    • MicroRNAs as therapeutic targets and their potential applications in cancer therapy
    • Cho WC: MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin Ther Targets 2012; 16: 747-759.
    • (2012) Expert Opin Ther Targets , vol.16 , pp. 747-759
    • Cho, W.C.1
  • 112
    • 84862109179 scopus 로고    scopus 로고
    • Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: A DBCG study
    • Lyng MB, Laenkholm AV, Sokilde R, et al: Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study. PLoS One 2012; 7:e36170.
    • (2012) PLoS One , vol.7 , pp. e36170
    • Lyng, M.B.1    Laenkholm, A.V.2    Sokilde, R.3
  • 114
    • 77649275464 scopus 로고    scopus 로고
    • MiR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
    • Ma L, Young J, Prabhala H, et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12:247-256.
    • (2010) Nat Cell Biol , vol.12 , pp. 247-256
    • Ma, L.1    Young, J.2    Prabhala, H.3
  • 115
    • 77952921840 scopus 로고    scopus 로고
    • Mi-croRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer
    • Di Leva G, Gasparini P, Piovan C, et al: Mi-croRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 2010; 102:706-721.
    • (2010) J Natl Cancer Inst , vol.102 , pp. 706-721
    • Di Leva, G.1    Gasparini, P.2    Piovan, C.3
  • 116
    • 57649174634 scopus 로고    scopus 로고
    • MicroR-NA-221/222 negatively regulates estrogen receptor alpha and is associated with tamox-ifen resistance in breast cancer
    • Zhao JJ, Lin J, Yang H, et al: MicroR-NA-221/222 negatively regulates estrogen receptor alpha and is associated with tamox-ifen resistance in breast cancer. J Biol Chem 2008; 283:31079-31086.
    • (2008) J Biol Chem , vol.283 , pp. 31079-31086
    • Zhao, J.J.1    Lin, J.2    Yang, H.3
  • 117
    • 79952281614 scopus 로고    scopus 로고
    • Micro-RNA-221/222 confers breast cancer fulves-trant resistance by regulating multiple signaling pathways
    • Rao X, di Leva G, Li M, et al: Micro-RNA-221/222 confers breast cancer fulves-trant resistance by regulating multiple signaling pathways. Oncogene 2011; 30:1082-1097.
    • (2011) Oncogene , vol.30 , pp. 1082-1097
    • Rao, X.1    Di Leva, G.2    Li, M.3
  • 118
    • 84930001098 scopus 로고    scopus 로고
    • Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells
    • Wei Y, Lai X, Yu S, et al: Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 2014; 47:423-231.
    • (2014) Breast Cancer Res Treat , vol.47 , pp. 423-431
    • Wei, Y.1    Lai, X.2    Yu, S.3
  • 119
    • 67650135755 scopus 로고    scopus 로고
    • MiR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA
    • Pandey DP, Picard D: miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA. Mol Cell Biol 2009; 29:3783-3790.
    • (2009) Mol Cell Biol , vol.29 , pp. 3783-3790
    • Pandey, D.P.1    Picard, D.2
  • 120
    • 38049115129 scopus 로고    scopus 로고
    • Endogenous human microRNAs that suppress breast cancer metastasis
    • Tavazoie SF, Alarcon C, Oskarsson T, et al: Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-152.
    • (2008) Nature , vol.451 , pp. 147-152
    • Tavazoie, S.F.1    Alarcon, C.2    Oskarsson, T.3
  • 121
    • 84874787674 scopus 로고    scopus 로고
    • MiR-124 targets Slug to regulate epithelial-mes-enchymal transition and metastasis of breast cancer
    • Liang YJ, Wang QY, Zhou CX, et al: MiR-124 targets Slug to regulate epithelial-mes-enchymal transition and metastasis of breast cancer. Carcinogenesis 2013; 34:713-722.
    • (2013) Carcinogenesis , vol.34 , pp. 713-722
    • Liang, Y.J.1    Wang, Q.Y.2    Zhou, C.X.3
  • 122
    • 78650179541 scopus 로고    scopus 로고
    • Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells
    • Li QQ, Chen ZQ, Cao XX, et al: Involvement of NF-kappaB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial-mesenchymal transition of breast cancer cells. Cell Death Differ 2011; 18:16-26.
    • (2011) Cell Death Differ , vol.18 , pp. 16-26
    • Li, Q.Q.1    Chen, Z.Q.2    Cao, X.X.3
  • 123
    • 84889970352 scopus 로고    scopus 로고
    • Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer
    • Li L, Luo J, Wang B, et al: Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol Cancer 2013; 12:1476-4598.
    • (2013) Mol Cancer , vol.12 , pp. 1476-4598
    • Li, L.1    Luo, J.2    Wang, B.3
  • 124
    • 84871067207 scopus 로고    scopus 로고
    • MiR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-meta-static genes in vitro
    • Lv XB, Jiao Y, Qing Y, et al: miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-meta-static genes in vitro. Chin J Cancer 2011; 30: 821-830.
    • (2011) Chin J Cancer , vol.30 , pp. 821-830
    • Lv, X.B.1    Jiao, Y.2    Qing, Y.3
  • 125
    • 84921341682 scopus 로고    scopus 로고
    • Micro-RNA-145 inhibits lung cancer metastasis
    • Ling DJ, Chen ZS, Zhang YD, et al: Micro-RNA-145 inhibits lung cancer metastasis. Mol Med Rep 2015; 11:3108-3114.
    • (2015) Mol Med Rep , vol.11 , pp. 3108-3114
    • Ling, D.J.1    Chen, Z.S.2    Zhang, Y.D.3
  • 126
    • 67349149082 scopus 로고    scopus 로고
    • MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells
    • Xu N, Papaginnakopoulos T, Pan G, et al: MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 2009; 137:647-658.
    • (2009) Cell , vol.137 , pp. 647-658
    • Xu, N.1    Papaginnakopoulos, T.2    Pan, G.3
  • 127
    • 84908059702 scopus 로고    scopus 로고
    • MicroR-NA-145: A potent tumor suppressor that regulates multiple cellular pathways
    • Cui S-Y, Wang R, Chen L-B: MicroR-NA-145: a potent tumor suppressor that regulates multiple cellular pathways. J Cell Mol Med 2014; 18:1913-1926.
    • (2014) J Cell Mol Med , vol.18 , pp. 1913-1926
    • Cui, S.-Y.1    Wang, R.2    Chen, L.-B.3
  • 128
    • 67650538055 scopus 로고    scopus 로고
    • Up-regu-lation of miR-21 by HER2/neu signaling promotes cell invasion
    • Huang TH, Wu F, Loeb GB, et al: Up-regu-lation of miR-21 by HER2/neu signaling promotes cell invasion. J Biol Chem 2009; 284:18515-18524.
    • (2009) J Biol Chem , vol.284 , pp. 18515-18524
    • Huang, T.H.1    Wu, F.2    Loeb, G.B.3
  • 129
    • 34547791273 scopus 로고    scopus 로고
    • Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
    • le Sage C, Nagel R, Egan DA, et al: Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 2007; 26:3699-3708.
    • (2007) EMBO J , vol.26 , pp. 3699-3708
    • Le Sage, C.1    Nagel, R.2    Egan, D.A.3
  • 130
    • 84887840885 scopus 로고    scopus 로고
    • MIR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
    • Falkenberg N, Anastosov N, Rappl K, et al: MIR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion. Br J Cancer 2013; 109: 2714-2723.
    • (2013) Br J Cancer , vol.109 , pp. 2714-2723
    • Falkenberg, N.1    Anastosov, N.2    Rappl, K.3
  • 131
    • 84928585732 scopus 로고    scopus 로고
    • MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer
    • Li W, Zang W, Liu P, et al: MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer. Tumour Biol 2014; 35:10897-10904.
    • (2014) Tumour Biol , vol.35 , pp. 10897-10904
    • Li, W.1    Zang, W.2    Liu, P.3
  • 132
    • 0036010596 scopus 로고    scopus 로고
    • Fas-cins and their roles in cell structure and function
    • Kureishy N, Sapountzi V, Prag S, et al: Fas-cins and their roles in cell structure and function. Bioessays 2002; 24:350-361.
    • (2002) Bioessays , vol.24 , pp. 350-361
    • Kureishy, N.1    Sapountzi, V.2    Prag, S.3
  • 133
    • 84860389407 scopus 로고    scopus 로고
    • Breast cancer cells migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase
    • McSherry EA, Brennan K, Hudson L, et al: Breast cancer cells migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res 2011; 13:1-14.
    • (2011) Breast Cancer Res , vol.13 , pp. 1-14
    • McSherry, E.A.1    Brennan, K.2    Hudson, L.3
  • 134
    • 75149124701 scopus 로고    scopus 로고
    • MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1
    • Sachdeva M, Mo YY: MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010; 70:378-387.
    • (2010) Cancer Res , vol.70 , pp. 378-387
    • Sachdeva, M.1    Mo, Y.Y.2
  • 135
    • 51349103144 scopus 로고    scopus 로고
    • Four miRi NAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer
    • Foekens JA, Sieuwerts AM, Smid M, et al: Four miRi NAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 2008; 105:13021-13026.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 13021-13026
    • Foekens, J.A.1    Sieuwerts, A.M.2    Smid, M.3
  • 136
    • 40949137731 scopus 로고    scopus 로고
    • Hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
    • Camps C, Buffa FM, Colella S, et al: hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008; 14:1340-1348.
    • (2008) Clin Cancer Res , vol.14 , pp. 1340-1348
    • Camps, C.1    Buffa, F.M.2    Colella, S.3
  • 137
    • 79959637929 scopus 로고    scopus 로고
    • Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer
    • Rothe F, Ignatiadis M, Chaboteaux C, et al: Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcome in breast cancer. PLoS One 2011; 6:e20980.
    • (2011) PLoS One , vol.6 , pp. e20980
    • Rothe, F.1    Ignatiadis, M.2    Chaboteaux, C.3
  • 138
    • 80052223077 scopus 로고    scopus 로고
    • Mi-croRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer
    • Buffa FM, Camps C, Winchester L, et al: mi-croRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 2011; 71:5635-5645.
    • (2011) Cancer Res , vol.71 , pp. 5635-5645
    • Buffa, F.M.1    Camps, C.2    Winchester, L.3
  • 139
    • 79851479816 scopus 로고    scopus 로고
    • MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
    • Radojicic J, Zaravinos A, Vrekoussis T, et al: MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 2011; 10:507-517.
    • (2011) Cell Cycle , vol.10 , pp. 507-517
    • Radojicic, J.1    Zaravinos, A.2    Vrekoussis, T.3
  • 140
    • 69049120925 scopus 로고    scopus 로고
    • High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1
    • Qian B, Katsaros D, Lu L, et al: High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 2009; 117:131-140.
    • (2009) Breast Cancer Res Treat , vol.117 , pp. 131-140
    • Qian, B.1    Katsaros, D.2    Lu, L.3
  • 141
    • 79956313718 scopus 로고    scopus 로고
    • Up-regulation of miR-21 mediates resistance to trastuzum-ab therapy for breast cancer
    • Gong C, Yao Y, Wang Y, et al: Up-regulation of miR-21 mediates resistance to trastuzum-ab therapy for breast cancer. J Biol Chem 2011; 286:19127-19137.
    • (2011) J Biol Chem , vol.286 , pp. 19127-19137
    • Gong, C.1    Yao, Y.2    Wang, Y.3
  • 142
    • 66449095667 scopus 로고    scopus 로고
    • A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis
    • Valastyan S, Reinhardt F, Benaich N, et al: A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009; 137:1032-1046.
    • (2009) Cell , vol.137 , pp. 1032-1046
    • Valastyan, S.1    Reinhardt, F.2    Benaich, N.3
  • 143
    • 66449136951 scopus 로고    scopus 로고
    • Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model
    • Kota J, Chivukula RR, O'Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137:1005-1017.
    • (2009) Cell , vol.137 , pp. 1005-1017
    • Kota, J.1    Chivukula, R.R.2    O'Donnell, K.A.3
  • 144
    • 28444469246 scopus 로고    scopus 로고
    • Silencing of microRNAs in vivo with 'an-tagomirs'
    • Krutzfeldt J, Rajewsky N, Braich R, et al: Silencing of microRNAs in vivo with 'an-tagomirs'. Nature 2005; 438:685-689.
    • (2005) Nature , vol.438 , pp. 685-689
    • Krutzfeldt, J.1    Rajewsky, N.2    Braich, R.3
  • 145
    • 40249106014 scopus 로고    scopus 로고
    • Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver
    • Elmen J, Lindow M, Silahtaroglu A, et al: Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver. Nucleic Acids Res 2008; 36:1153-1162.
    • (2008) Nucleic Acids Res , vol.36 , pp. 1153-1162
    • Elmen, J.1    Lindow, M.2    Silahtaroglu, A.3
  • 146
    • 37349113774 scopus 로고    scopus 로고
    • Inhibition of microRNA with an-tisense oligonucleotides
    • Esau CC: Inhibition of microRNA with an-tisense oligonucleotides. Methods 2008; 44: 55-60.
    • (2008) Methods , vol.44 , pp. 55-60
    • Esau, C.C.1
  • 147
    • 34247495591 scopus 로고    scopus 로고
    • MiR-21-mediated tumor growth
    • Si ML, Zhu S, Wu H, et al: miR-21-mediated tumor growth. Oncogene 2007; 26:2799-2803.
    • (2007) Oncogene , vol.26 , pp. 2799-2803
    • Si, M.L.1    Zhu, S.2    Wu, H.3
  • 148
    • 55549120234 scopus 로고    scopus 로고
    • MicroRNA miR-21 over-expression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
    • Yan LX, Huang XF, Shao Q, et al: MicroRNA miR-21 over-expression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008; 14:2348-2360.
    • (2008) RNA , vol.14 , pp. 2348-2360
    • Yan, L.X.1    Huang, X.F.2    Shao, Q.3
  • 149
    • 74249112787 scopus 로고    scopus 로고
    • Therapeutic silencing of micro-RNA-122 in primates with chronic hepatitis C virus infection
    • Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al: Therapeutic silencing of micro-RNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327:198-201.
    • (2010) Science , vol.327 , pp. 198-201
    • Lanford, R.E.1    Hildebrandt-Eriksen, E.S.2    Petri, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.